Page last updated: 2024-08-21

thymoquinone and Cirrhoses, Experimental Liver

thymoquinone has been researched along with Cirrhoses, Experimental Liver in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abd Al Haleem, EN; Awad, AS; El-Bakly, WM; Sherief, MA	1

Other Studies

1 other study(ies) available for thymoquinone and Cirrhoses, Experimental Liver

Article	Year
Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis. Naunyn-Schmiedeberg's archives of pharmacology, 2016, Volume: 389, Issue:4 Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Benzoquinones; Diet, High-Fat; Hepatitis; Inflammation Mediators; Insulin Resistance; Interleukin-10; Lipids; Liver; Liver Cirrhosis, Experimental; Male; Non-alcoholic Fatty Liver Disease; Oxidative Stress; PPAR gamma; Proto-Oncogene Proteins c-bcl-2; Rats, Wistar; Tumor Necrosis Factor-alpha	2016

Article

Year

Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis.

Naunyn-Schmiedeberg's archives of pharmacology, 2016, Volume: 389, Issue:4

Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Benzoquinones; Diet, High-Fat; Hepatitis; Inflammation Mediators; Insulin Resistance; Interleukin-10; Lipids; Liver; Liver Cirrhosis, Experimental; Male; Non-alcoholic Fatty Liver Disease; Oxidative Stress; PPAR gamma; Proto-Oncogene Proteins c-bcl-2; Rats, Wistar; Tumor Necrosis Factor-alpha

2016